Koninklijke Philips NV ADR

Koninklijke Philips N.V. (Royal Philips) is a health technology company focused on improving people's health and well-being through meaningful innovation. The company operates through three business segments: Diagnosis & Treatment (including Precision Diagnosis and Image Guided Therapy systems such as MRI, CT, and the Azurion interventional platform), Connected Care (including patient monitoring, hospital-at-home solutions, enterprise imaging, and remote patient monitoring), and Personal Health (including oral healthcare under the Sonicare brand, personal care shavers, and beauty devices like Lumea IPL). Philips serves healthcare providers, hospitals, and consumers worldwide across both mature markets (North America, Western Europe) and growth geographies (Central Eastern Europe, Latin America, Indian subcontinent, China). The company is actively integrating AI-powered innovations across its product portfolio, including its new Titanion MR next-generation MRI system, and pursuing a multi-year productivity program targeting EUR 1.5 billion in savings from 2026-2028. Philips recently acquired SpectraWAVE, Inc., an innovator in Enhanced Vascular Imaging of coronary arteries and AI-powered medical imaging, strengthening its Image Guided Therapy portfolio. The company continues to manage ongoing legal proceedings related to its Respironics recall, including investigations by the US Department of Justice, SEC, and State Attorneys General across 41 US states and territories. As of June 30, 2026, Philips had approximately 63,670 employees and 977.4 million common shares outstanding. Updated Jul 28, 2026